# A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried

> **NCT07021703** · PHASE1 · RECRUITING · sponsor: **Ningbo Rongan Biological Pharmaceutical Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** Freeze-dried Human Rabies Vaccine（Human Diploid Cell）, Essen
- **BIOLOGICAL:** Freeze-dried Human Rabies Vaccine（Human Diploid Cell），Zagreb

## Key facts

- **NCT ID:** NCT07021703
- **Lead sponsor:** Ningbo Rongan Biological Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-23
- **Primary completion:** 2025-07-28
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07021703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07021703, "A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT07021703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*